Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 1;173(5):W87.
doi: 10.7326/L20-0969. Epub 2020 Jul 23.

Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey  1 , Devan Kansagara  1 , Kathryn Vela  1
Affiliations
Comment

Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey et al. Ann Intern Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L20-0969.

Comment on

References

    1. Mackey K, King VJ, Gurley S, et al. Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults. Ann Intern Med. 15 May 2020. [Epub ahead of print]. [PMID: 32422062] doi:10.7326/M20-1515 - PMC - PubMed
    1. Flacco ME, Acuti Martellucci C, Bravi F, et al. Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis. Heart. 2020. [PMID: 32611676] doi:10.1136/heartjnl-2020-317336 - PMC - PubMed
    1. Grover A, Oberoi M. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Eur Heart J Cardiovasc Pharmacother. 2020. [PMID: 32542337] doi:10.1093/ehjcvp/pvaa064 - PMC - PubMed
    1. Pirola CJ, Sookoian S. Estimation of renin-angiotensin-aldosterone-system (RAAS)-inhibitor effect on COVID-19 outcome: a meta-analysis. J Infect. 2020. [PMID: 32474043] doi:10.1016/j.jinf.2020.05.052 - PMC - PubMed
    1. Bravi F, Flacco ME, Carradori T, et al. Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers, in a sample of infected Italian citizens. PLoS One. 2020;15:e0235248. [PMID: 32579597] doi:10.1371/journal.pone.0235248 - PMC - PubMed

Substances